v3.22.2.2
REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Total net product sales $ 167,466 $ 127,722 $ 494,868 $ 382,339
EXPAREL        
Disaggregation of Revenue [Line Items]        
Total net product sales 132,642 121,926 398,854 366,663
ZILRETTA        
Disaggregation of Revenue [Line Items]        
Total net product sales 26,494 0 77,546 0
iovera°        
Disaggregation of Revenue [Line Items]        
Total net product sales 4,467 4,182 10,694 11,264
Bupivacaine liposome injectable suspension        
Disaggregation of Revenue [Line Items]        
Total net product sales 2,957 683 5,469 2,465
Total net product sales        
Disaggregation of Revenue [Line Items]        
Total net product sales $ 166,560 $ 126,791 $ 492,563 $ 380,392